フェロプトーシスと頭頸部がん:メカニズムと治療の見通し (レビュー)

Chenglin Kang¹, Xiaomei Li², Xudong Wei¹

¹The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu 730000, P.R. China.

International journal of molecular medicine

|September 5, 2025

まとめ

頭頸部がん (HNC) には複雑な病原性があります. このレビューは,鉄に依存する細胞死であるフェロプトーシスと,HNCの発達,治療,および結果におけるその重要な役割を調査します.

科学分野:

耳鼻喉科
腫瘍学
細胞生物学

背景:

頭頸部がん (HNC) は,完全には解明されていない悪性腫瘍である.
現在のHNC治療には手術,放射線治療,化学療法,免疫療法が含まれていますが,しばしば機能的欠損につながり,患者の生活の質に影響します.
繰り返し発生するHNCは,再処理に重大な課題をもたらす.

研究の目的:

頭頸部がんにおけるフェロプトーシスの役割を明らかにする.
フェロプトーシスに影響を与える臓器細胞を記述する.
HNCにおけるフェロプトーシスを活性化または阻害する要因を特定する.

主な方法:

フェロプトーシスとHNCに関する科学文献のレビュー
フェロプトーシスに関与する細胞機構の分析.
HNCの病原性,治療,および予後に対するフェロプトーシスの影響の検討.

主要な成果:

鉄に依存する調節された細胞死と脂質過酸化によって特徴づけられるフェロプトーシスは,HNCに関与している.
特定の臓器細胞と因子はHNCの文脈でフェロプトーシスを調節する.
フェロプトーシスは,HNCの発達,治療反応,および全体的な予後に影響を与える.

結論:

フェロプトーシスは頭頸部がんの重要な生物学的プロセスです
フェロプトーシスメカニズムの理解は,新しいHNC治療戦略の可能性を秘めています.
フェロプトーシスをターゲットにすることで,HNCの治療効果と患者のアウトカムが改善される可能性があります.

キーワード:

細胞死フェロプトーシス頭頸部がんアイアン脂質過酸化

さらに関連する動画

06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.9K

07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K

関連する概念動画

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

7.8K

02:49

Cancer Therapies

7.9K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

7.9K

02:56

Treatment Resistant Cancers

3.4K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

3.4K

02:53

Adaptive Mechanisms in Cancer Cells

5.9K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

5.9K

01:16

Necrosis

4.8K

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...